Lamotrigine, an anticonvulsant and mood stabilizer, modulates voltage-gated sodium channels and glutamate release, potentially reducing neuronal hyperexcitability associated with Visual Snow Syndrome. By stabilizing neuronal membranes and decreasing glutamatergic neurotransmission, it may help mitigate the persistent visual disturbances characteristic of the syndrome.